Tue, October 16, 2018
Mon, October 15, 2018
Fri, October 12, 2018

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $186 on, Oct 15th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-186-on-oct-15th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $190 to $186 on, Oct 15th, 2018.

Matthew has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $230 on, Tuesday, June 19th, 2018